DSM to acquire Aland (China) to strengthen vitamin C position
11 July 2014 - 4:15PM
Royal DSM,
the global Life Sciences and Materials
Sciences company, announces today it
has reached agreement to acquire Aland (HK) Holding Limited
("Aland"), a Hong Kong-based company producing vitamin C in
mainland China. Financial details will not be disclosed at this
time. Subject to customary
conditions, the transaction is expected to close in the next six to
nine months. DSM previously announced on 9 April 2014 that it was
in exclusive discussions to acquire Aland.
Acquiring Aland, one of the leading Vitamin C
manufacturers in China, allows DSM to further strengthen its
position in vitamin C. Aland increases DSM's global footprint in
vitamins for Human Nutrition & Health, Animal Nutrition &
Health and Personal Care. DSM remains fully committed to its
current vitamin C manufacturing facility in Dalry (Scotland, United
Kingdom). The acquisition fully meets DSM's financial and strategic
requirements.
Aland was founded in 1990 and has a production
facility in Jingjiang, Jiangsu Province in China. In 2013 the
company realized net sales of about USD 90 million in vitamin C
with around 1,850 employees. The transaction excludes Aland's
consumer health activities. DSM plans to invest in Aland's
production facilities for operational excellence including quality
and environmental performance.
Vitamin C, the world's largest vitamin measured by
volume, is an essential health ingredient that the body cannot
produce itself and that needs to be absorbed through diet or
supplementation. Vitamin C is widely found in fruit and vegetables.
The recommended dietary allowances for vitamin C in the United
States were recently revised upwards to 90 mg/day for men and 75
mg/day for women.
DSM - Bright Science.
Brighter Living.(TM)
Royal DSM is a global science-based company active in health,
nutrition and materials. By connecting its unique competences in
Life Sciences and Materials Sciences DSM is driving economic
prosperity, environmental progress and social advances to create
sustainable value for all stakeholders simultaneously. DSM delivers
innovative solutions that nourish, protect and improve performance
in global markets such as food and dietary supplements, personal
care, feed, medical devices, automotive, paints, electrical and
electronics, life protection, alternative energy and bio-based
materials. DSM's 24,500 employees deliver annual net sales of
around €10 billion. The company is listed on NYSE Euronext. More
information can be found at www.dsm.com.
Or find us on:
For more
information:
DSM
Corporate Communications Herman Betten
tel.+31(0)455782017
e-mail media.contacts@dsm.com |
DSM
Investor Relations Dave Huizing
tel. +31 (0) 45 5782864
email investor.relations@dsm.com |
Press release-pdf
This
announcement is distributed by NASDAQ OMX Corporate Solutions on
behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: DSM N.V. via Globenewswire
HUG#1821890
Royal DSM NV (QX) (USOTC:RDSMY)
Historical Stock Chart
From Apr 2024 to May 2024
Royal DSM NV (QX) (USOTC:RDSMY)
Historical Stock Chart
From May 2023 to May 2024